XML 12 R2.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Condensed Consolidated Balance Sheets (unaudited) - USD ($)
$ in Thousands
Mar. 31, 2024
Dec. 31, 2023
Current Assets    
Cash and cash equivalents $ 21,548 $ 27,606
Accounts receivable, net of allowance of $470 and $757, at March 31, 2024, and December 31, 2023, respectively 35,733 33,906
Prepaid expenses 6,791 4,190
Deferred charges 3,578 3,635
Other current assets 765 2,413
Total current assets 68,415 71,750
Restricted cash 605 1,392
Property and equipment, net 1,575 1,576
Capitalized software development costs, net 8,132 7,433
Intangible assets, net 79,217 82,332
Goodwill 275,703 275,703
Right-of-use assets 3,046 3,362
Other assets 1,052 1,047
Total assets 437,745 444,595
Current Liabilities    
Accounts payable 3,466 3,526
Accrued expenses and other current liabilities 25,493 22,934
Current maturities of long-term debt, net 15,000 15,000
Deferred revenue 19,070 19,181
Total current liabilities 63,029 60,641
Long-term debt, net 300,049 325,600
Warrant liability 86,302 67,622
Lease liability 1,856 2,241
Deferred tax liability 4,558 4,665
Other non-current liabilities 3,968 2,118
Total liabilities 459,762 462,887
Commitments and Contingencies (Note 14)
Stockholders’ Deficit    
Preferred stock, par value $0.0001; $100,000,000 shares authorized; none issued and outstanding at March 31, 2024, and December 31, 2023, respectively 0 0
Common stock, par value $0.0001; $1,000,000,000 shares authorized; $175,905,799 and $175,377,711 shares issued at March 31, 2024, and December 31, 2023, respectively; $175,391,283 and $175,020,471 outstanding at March 31, 2024, and December 31, 2023, respectively 18 18
Treasury stock (3,648) (2,154)
Additional paid-in capital 51,830 44,655
Accumulated deficit (70,217) (60,811)
Total stockholders’ deficit (22,017) (18,292)
Total liabilities and stockholders’ deficit $ 437,745 $ 444,595